Expert in Biotech/Pharma; Marketing Rare Disease and Specialty Products
Expert ID: 737078 Switzerland
|Year: 2002||Degree: MBA||Subject: Business Administration||Institution: ESCP|
|Year: 1995||Degree: MSc||Subject: Biotechnology||Institution: UST Lille 1|
|Years: 2021 to Present||Employer: Undisclosed||Title: Global Brand Leader||Department: Hematology|
Responsibilities:Driving Doptelet ex-US brand strategy in two rare hematology disease indications.
Supporting ex-US launches and fine-tuning the product positioning to maximize market penetration.
Preparing the commercial launch of a Patient Support MedDev. App. Defining and deploying the brand multichannel/digital strategy.
Developing long-term LCM plan ensuring continuous differentiation to face increasing
|Years: 2019 to 2021||Employer: Takeda||Title: Senior Director Global Strategic Marketing||Department: Gastro-enterology|
Responsibilities:Headed Gattex/Revestive (SBS-IF indication) brand strategy. Drove the Global Brand Planning process.
Defined the multi-channel communication strategy for the brand aimed at improving patients’ diagnoses.
Drove the “ATLAS” European Public Affairs initiative with my European counterpart, targeting an increased recognition of intestinal failure.
Oversaw commercial development of a new generation reconstitution/injection device.
|Years: 2014 to 2019||Employer: Shire||Title: Global Commercial Lead||Department: Neuroscience|
Responsibilities:Headed the Child & Adolescent Neuroscience Portfolio strategy with responsibility for Vyvanse, Intuniv, Equasym (ADHD) & BUCCOLAM (Pediatric epilepsy rescue medication).
Partnered with affiliates in preparing and optimizing product launches from L-24. Responsible to give Go/No Go at L-6, together with General Manager. Improved the commercial excellence capabilities in partnership with the International Commercial Team.
Responsible for the development and implementation of Global Brand Plans & Target Product Profiles.
Supervised symposiums, roadshows, speaker consortiums and webinars, and presence at congresses.
|Years: 2012 to 2014||Employer: Anteis||Title: Head of Marketing and Medical Communication||Department: Healthcare|
Responsibilities:Led marketing strategy and activity for implantable devices portfolio (hyaluronic acid) in Ophthalmology and Rheumatology.
Headed a small team on preparation of Marketing and Communication activities such as congresses, symposiums, and website and managed the development of Marketing and Business Plans.
Launched one new product in cataract surgery: Rhexicoat. In addition, it redefined Synolis VA’s positioning in orthopedic visco-supplementation and developed a new global marketing campaign.
Acting Medical Communication Director, managed scientific communication, post-marketing studies, and KOL relationship; developed scientific posters for congresses and presented symposia in Europe and Asia.
Drove the Marketing Strategic Plan review process for the entire company (Healthcare & Esthetics).
|Years: 2008 to 2012||Employer: Merck KGaA||Title: Director Global Strategic Marketing||Department: Endocrinology|
Responsibilities:In charge of Saizen, a human Growth Hormone (hGH) indicated in pediatric deficiency.
Co-led, with the Program Manager, development of a new liquid formulation of Saizen and led the final development of cool.click2, a needle-free injection device, both launched at an international level, proactively taking on cool.click2 outside allocated areas of responsibility to get it to market on time.
Prepared the organization and the market for the launch of Saizen liquid for 2 years, and launched this new formulation in several international countries.
Developed and deployed global marketing plans for the Saizen franchise (2 formulations, 3 injection devices, and communication software) and managed the product life cycle for each.
Developed a business concept for pharmacogenetic-based service, delivering treatment prognosis based on genetic mutation profiling with the aim of increasing the perceived value of the product.
Created patient-focused tactics, promotional campaigns, and training material and organized advisory boards.